Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer

被引：4
|
作者：
Morganti, Stefania [1 ,2 ,3 ,4 ,5 ]
Tolaney, Sara M. [1 ,2 ,6 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA USA
[2] Dana Farber Brigham Canc Ctr, Breast Oncol Program, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
[4] Broad Inst & Harvard, Boston, MA USA
[5] Univ Milan, Ist Europeo Oncol, Dept Oncol & Hemato Oncol, Milan, Italy
[6] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 01期
关键词：
TNBC; Breast cancer; Immunotherapy; Biomarkers; PDL1; Immune checkpoint inhibitors; PEMBROLIZUMAB PLUS CHEMOTHERAPY; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; DOUBLE-BLIND; PLACEBO; ATEZOLIZUMAB; PACLITAXEL; MELANOMA; TNBC;
D O I：
10.1016/j.hoc.2022.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：133 / 150
页数：18
相关论文
共 50 条
  • [1] Obesity is associated with a late-stage diagnosis in triple-negative breast cancer
    Aranda-Gutierrez, A.
    Ferrigno, A. S.
    Moncada-Madrazo, M.
    Gomez-Picos, A.
    De la Garza-Ramos, C.
    Mesa-Chavez, F.
    Diaz-Perez, H.
    Cardona, S.
    Ortiz-Lopez, R.
    Villarreal-Garza, C.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S31 - S31
  • [2] Advancing immunotherapy for early-stage triple-negative breast cancer
    Di Cosimo, Serena
    [J]. LANCET, 2020, 396 (10257): : 1046 - 1048
  • [3] Role of Immunotherapy in Triple-Negative Breast Cancer
    Keenan, Tanya E.
    Tolaney, Sara M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (04): : 479 - 489
  • [4] Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer
    Nederlof, Iris
    Voorwerk, Leonie
    Kok, Marleen
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2362 - 2370
  • [5] Role of Platinum in Early-Stage Triple-Negative Breast Cancer
    La Belle, Alyssa
    Khatib, Jude
    Schiemann, William P.
    Vinayak, Shaveta
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (11)
  • [6] Role of Platinum in Early-Stage Triple-Negative Breast Cancer
    Alyssa La Belle
    Jude Khatib
    William P. Schiemann
    Shaveta Vinayak
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [7] Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
    Savas, Peter
    Loi, Sherene
    [J]. CANCER CELL, 2020, 37 (05) : 623 - 624
  • [8] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    [J]. CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [9] Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
    Shuang Zhang
    Yu Dong
    Xiuping Chen
    Chris Soon Heng TAN
    Min Li
    Kai Miao
    Jia-Hong Lu
    [J]. Chinese Medicine, 17
  • [10] Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
    Zhang, Shuang
    Dong, Yu
    Chen, Xiuping
    Tan, Chris Soon Heng
    Li, Min
    Miao, Kai
    Lu, Jia-Hong
    [J]. CHINESE MEDICINE, 2022, 17 (01)
12345